Chemical Structure (Image 01)
Voriconazole Powder, For Suspension
Product Images NDC 70436-230
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 70436-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Picture1 (Image 02)
Picture2 (Image 03)
Picture3 (Image 04)
Picture4 (Image 05)
Picture5 (Image 06)
Picture6 (Image 07)
Picture7 (Image 08)
Picture8 (Image 09)
Picture9 (Image 10)
Picture10 (Image 11)
40 mg/ml Bottle Label (Image 12)
This is a description of Voriconazole Oral Suspension, which is an orange-flavored medication. Each bottle contains 75 mL when reconstituted and has a total of 3 grams of voriconazole. The instructions mention storing the dry powder refrigerated before reconstitution and the suspension at controlled room temperature afterward. It is essential not to refrigerate or freeze the suspension, and any unused portion should be discarded 14 days after reconstitution. The mixing directions involve adding water to the bottle and shaking it vigorously for a minute. Before each use, the bottle should be shaken for 10 seconds. The text also provides information on the dosage, reconstitution date, manufacturer details, and distributor information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
